Onconetix Statistics

Total Valuation

Onconetix has a market cap or net worth of $2.52 million. The enterprise value is $10.03 million.

Market Cap	2.52M
Enterprise Value	10.03M

Important Dates

The last earnings date was Thursday, June 12, 2025, after market close.

Earnings Date	Jun 12, 2025
Ex-Dividend Date	n/a

Share Statistics

Onconetix has 521,863 shares outstanding.

Current Share Class	521,863
Shares Outstanding	521,863
Shares Change (YoY)	n/a
Shares Change (QoQ)	+112.29%
Owned by Insiders (%)	3.01%
Owned by Institutions (%)	0.77%
Float	460,873

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.20
Forward PS	n/a
PB Ratio	0.50
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	5.21
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.17, with a Debt / Equity ratio of 2.00.

Current Ratio	0.17
Quick Ratio	0.12
Debt / Equity	2.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-5.08

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-8.25%
Return on Invested Capital (ROIC)	-53.46%
Return on Capital Employed (ROCE)	-130.64%
Revenue Per Employee	$385,063
Profits Per Employee	-$11.50M
Employee Count	5
Asset Turnover	0.04
Inventory Turnover	3.67

Taxes

Income Tax	-923,613
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -99.08% in the last 52 weeks. The beta is 3.51, so Onconetix's price volatility has been higher than the market average.

Beta (5Y)	3.51
52-Week Price Change	-99.08%
50-Day Moving Average	5.89
200-Day Moving Average	105.49
Relative Strength Index (RSI)	43.56
Average Volume (20 Days)	222,592

Short Selling Information

The latest short interest is 45,512, so 8.72% of the outstanding shares have been sold short.

Short Interest	45,512
Short Previous Month	1.84M
Short % of Shares Out	8.72%
Short % of Float	9.88%
Short Ratio (days to cover)	0.09

Income Statement

In the last 12 months, Onconetix had revenue of $1.93 million and -$57.49 million in losses. Loss per share was -$683.39.

Revenue	1.93M
Gross Profit	911,930
Operating Income	-6.19M
Pretax Income	-45.82M
Net Income	-57.49M
EBITDA	-5.66M
EBIT	-6.19M
Loss Per Share	-$683.39

Full Income Statement

Balance Sheet

The company has $1.58 million in cash and $9.05 million in debt, giving a net cash position of -$7.47 million or -$14.31 per share.

Cash & Cash Equivalents	1.58M
Total Debt	9.05M
Net Cash	-7.47M
Net Cash Per Share	-$14.31
Equity (Book Value)	4.52M
Book Value Per Share	9.23
Working Capital	-11.62M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$7.26 million and capital expenditures -$23,893, giving a free cash flow of -$7.29 million.

Operating Cash Flow	-7.26M
Capital Expenditures	-23,893
Free Cash Flow	-7.29M
FCF Per Share	-$13.96

Full Cash Flow Statement

Margins

Gross Margin	47.37%
Operating Margin	-321.38%
Pretax Margin	-2,962.74%
Profit Margin	n/a
EBITDA Margin	-293.89%
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Onconetix does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-2,248.41%
FCF Yield	-284.98%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on June 13, 2025. It was a reverse split with a ratio of 0.0117647:1.

Last Split Date	Jun 13, 2025
Split Type	Reverse
Split Ratio	0.0117647:1

Scores

Onconetix has an Altman Z-Score of -10.72 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-10.72
Piotroski F-Score	3